Atea Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation
Atea Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Atea Pharmaceuticals, Inc. (AVIR) Q3 2026 Earnings Call Transcript
Atea Pharma (AVIR) Q3 2026 Earnings Call Transcript
Atea Pharmaceuticals (NASDAQ:AVIR) Posts Narrower Q3 Loss as C-FORWARD Readout Looms
What Atea Pharmaceuticals (AVIR) Said on Its Q3 Earnings Call
CORRECTION: Atea Pharmaceuticals Q3 EPS $(0.40) Beats $(0.42) Estimate
Atea Pharmaceuticals Q3 2026 Earnings Call Transcript
Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital
Atea Pharmaceuticals to Host Third Quarter 2026 Financial Results and Business Update Conference Call on November 9, 2026
Atea Pharmaceuticals, Inc. (AVIR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Atea (AVIR) Q2 2026 Earnings Call Transcript
Morgan Stanley Maintains Equal-Weight on Atea Pharmaceuticals, Raises Price Target to $7
Atea Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Atea Pharmaceuticals Q2 Earnings Call Highlights
Atea Pharmaceuticals, Inc. (AVIR) Q2 2026 Earnings Call Transcript
Atea Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Atea Pharmaceuticals to Host Second Quarter 2026 Financial Results and Business Update Conference Call on August 12, 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.